Xenon Pharmaceuticals Inc (XENE)
39.80
+0.46
(+1.17%)
USD |
NASDAQ |
Nov 21, 16:00
38.11
-1.69
(-4.25%)
Pre-Market: 08:04
Xenon Pharmaceuticals Market Cap: 3.034B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.034B |
| November 20, 2024 | 2.999B |
| November 19, 2024 | 2.962B |
| November 18, 2024 | 2.921B |
| November 15, 2024 | 3.037B |
| November 14, 2024 | 3.183B |
| November 13, 2024 | 3.200B |
| November 12, 2024 | 3.308B |
| November 11, 2024 | 3.360B |
| November 08, 2024 | 3.431B |
| November 07, 2024 | 3.487B |
| November 06, 2024 | 3.426B |
| November 05, 2024 | 3.284B |
| November 04, 2024 | 3.161B |
| November 01, 2024 | 3.160B |
| October 31, 2024 | 3.116B |
| October 30, 2024 | 3.175B |
| October 29, 2024 | 3.167B |
| October 28, 2024 | 3.164B |
| October 25, 2024 | 3.163B |
| October 24, 2024 | 3.172B |
| October 23, 2024 | 3.158B |
| October 22, 2024 | 3.239B |
| October 21, 2024 | 3.351B |
| October 18, 2024 | 3.400B |
| Date | Value |
|---|---|
| October 17, 2024 | 3.283B |
| October 16, 2024 | 3.230B |
| October 15, 2024 | 3.086B |
| October 14, 2024 | 3.165B |
| October 11, 2024 | 3.123B |
| October 10, 2024 | 3.063B |
| October 09, 2024 | 2.988B |
| October 08, 2024 | 3.109B |
| October 07, 2024 | 3.076B |
| October 04, 2024 | 3.087B |
| October 03, 2024 | 3.009B |
| October 02, 2024 | 3.095B |
| October 01, 2024 | 3.061B |
| September 30, 2024 | 2.984B |
| September 27, 2024 | 2.928B |
| September 26, 2024 | 2.909B |
| September 25, 2024 | 2.884B |
| September 24, 2024 | 2.950B |
| September 23, 2024 | 3.004B |
| September 20, 2024 | 3.042B |
| September 19, 2024 | 3.090B |
| September 18, 2024 | 3.037B |
| September 17, 2024 | 3.037B |
| September 16, 2024 | 3.029B |
| September 13, 2024 | 3.094B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
242.65M
Minimum
Nov 22 2019
3.772B
Maximum
Feb 09 2024
1.711B
Average
1.729B
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals Inc | 1.256B |
| Edesa Biotech Inc | 6.852M |
| Lexaria Bioscience Corp | 34.15M |
| ESSA Pharma Inc | 78.09M |
| ImmunoPrecise Antibodies Ltd | 9.726M |
Market Cap Related Metrics
| PS Ratio | 229.02 |
| PEG Ratio | -1.040 |
| Price to Book Value | 3.803 |
| Price | 39.80 |
| Earnings Yield | -7.09% |
| PEGY Ratio | -1.040 |